Finance

Lists
RMD:NYSE
Resmed Inc
230,64 USD
+0,33%
(+0,76) 1D
12-окт., 10:18:40 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for RMD...
Open
231,74 USD
High
232,40 USD
Low
230,59 USD
Mkt. cap
32,44 млд
Avg. vol.
1,20 млн
Volume
107,90 миң
Dividend
1,14%
Quarterly dividend
0,66 USD
Ex-dividend date
2026-ж., 20-авг.
P/E ratio
22,11
52-wk high
277,67 USD
52-wk low
180,26 USD
EPS
10,43 USD
Beta
0,75
Shares outstanding
140,64 млн
No. of employees
11 миң
Open
231,74 USD
High
232,40 USD
Low
230,59 USD
Mkt. cap
32,44 млд
Avg. vol.
1,20 млн
Volume
107,90 миң
Dividend
1,14%
Quarterly dividend
0,66 USD
Ex-dividend date
2026-ж., 20-авг.
P/E ratio
22,11
52-wk high
277,67 USD
52-wk low
180,26 USD
EPS
10,43 USD
Beta
0,75
Shares outstanding
140,64 млн
No. of employees
11 миң
News stories
From web sources and news partners
Benzinga
Benzinga
·
2 саат мурун
ResMed Q4 2026 Earnings Call Transcript
The Motley Fool Australia
The Motley Fool Australia
·
14 саат мурун
Buy, hold, sell: Resmed, Megaport, ANZ shares
Investing.com Nigeria
Investing.com Nigeria
·
1 күн мурун
Form 144 RESMED INC For: 10 October By Investing.com
Profile
Resmed Inc. is a medical equipment company based in San Diego, California, and founded in Australia. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea, chronic obstructive pulmonary disease, and other respiratory conditions. Resmed produced hundreds of thousands of ventilators and bilevel devices to help treat the respiratory symptoms of patients with COVID-19. Resmed also provides software to out-of-hospital care agencies to streamline transitions of care into and between these care settings for seniors and their care providers. Resmed employs more than 8,000 people worldwide as of June 2022. The company operates in more than 140 countries worldwide, and has manufacturing facilities in Australia, Singapore, France, and the United States. Revenue was US$4.7 billion in fiscal year 2024. Wikipedia
About Resmed Inc
CEOMichael J. Farrell
Employees11,4 миң
Foundedиюн. 1989
HeadquartersСан Диего, Калифорния, Америка Кошмо Штаттары
SectorMedical device
Websiteresmed.com
Analyst ratings
Based on 14 analysts giving stock ratings to RMD in the past 3 months
Buy
Buy
5
Hold
9
Sell
0
12-month forecast
Based on 14 Wall Street analysts offering 12 month price targets for RMD in the last 3 months.
Highest
Current 230,64 USD
320,00 USD (+38,74%)
Average
242,91 USD (+5,32%)
Lowest
213,00 USD (-7,65%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jonathan Block
Stifel Nicolaus
Hold
Maintained
235,00 USD
+1,9%
10/02/2026
Craig Wong-Pan
RBC Capital
Buy
Upgraded
262,00 USD
+13,6%
09/15/2026
Laura Sutcliffe
Citi
Hold
Maintained
240,00 USD
+4,1%
09/10/2026
Brett Fishbin
KeyBanc
Buy
Reiterated
267,00 USD
+15,8%
08/31/2026
Jackson Philips
Rothschild & Co Redburn
Hold
Initiated
230,00 USD
-0,3%
08/19/2026
Anthony Petrone
Mizuho Securities
Buy
Maintained
235,00 USD
+1,9%
08/11/2026
Unknown Analyst
Oppenheimer
Hold
Reiterated
-
-
08/07/2026
Adam Maeder
Piper Sandler
Hold
Maintained
225,00 USD
-2,4%
08/07/2026
David Rescott
Robert W. Baird
Hold
Maintained
213,00 USD
-7,6%
08/07/2026
Nathan Treybeck
Wells Fargo
Hold
Reiterated
215,00 USD
-6,8%
08/07/2026
Brandon Vazquez
William Blair
Buy
Maintained
-
-
08/07/2026
Michael Matson
Needham
Hold
Maintained
-
-
08/07/2026
Lyanne Harrison
Bank of America Securities
Buy
Maintained
320,00 USD
+38,7%
07/29/2026
David Bailey
Morgan Stanley
Hold
Maintained
230,00 USD
-0,3%
07/13/2026
Matthew Taylor
Jefferies
Hold
Maintained
225,00 USD
-2,4%
07/10/2026
Unknown Analyst
Jefferies
Hold
Reiterated
225,00 USD
-2,4%
07/10/2026
Unknown Analyst
Wells Fargo
Hold
Maintained
227,00 USD
-1,6%
05/01/2026
Unknown Analyst
J.P. Morgan
Buy
Maintained
-
-
04/15/2026
Chris Cooper
J.P. Morgan
Buy
Initiated
-
-
04/15/2026
Unknown Analyst
Evercore ISI
Buy
Maintained
255,00 USD
+10,6%
04/13/2026
Larry Biegelsen
Wells Fargo
Hold
Maintained
270,00 USD
+17,1%
01/30/2026
Mark Wilson CFA
RBC Capital
Buy
Maintained
314,00 USD
+36,1%
01/30/2026
Last report
2026-ж., 6-авг.
Fiscal period
Q4 2026
2,95 USD / 2,89 USD
+1,98%beat
Revenue / Est. (USD)
1,46 млд / 1,46 млд
+0,21%beat
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
1,34 млд
1,42 млд
1,43 млд
1,46 млд
Cost of goods sold
506,94 млн
536,28 млн
532,58 млн
594,13 млн
Cost of revenue
506,94 млн
536,28 млн
532,58 млн
594,13 млн
Research and development expenses
87,32 млн
90,97 млн
94,27 млн
105,72 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
259,19 млн
275,70 млн
279,80 млн
293,36 млн
Operating expense
366,29 млн
386,24 млн
393,16 млн
417,88 млн
Total operating expenses
873,24 млн
922,51 млн
925,74 млн
1,01 млд
Operating income
462,35 млн
500,30 млн
505,67 млн
451,64 млн
Other non operating income
-3,84 млн
42,00 миң
181,00 миң
4,40 млн
EBT including unusual items
446,79 млн
496,15 млн
502,31 млн
474,16 млн
EBT excluding unusual items
468,79 млн
504,48 млн
518,30 млн
476,09 млн
Income tax expense
98,26 млн
103,56 млн
103,58 млн
90,73 млн
Effective tax rate
21,99%
20,87%
20,62%
19,14%
Other operating expenses
-
-
-
-
Net income
348,54 млн
392,59 млн
398,73 млн
383,43 млн
Net profit margin
26,10%
27,59%
27,86%
26,20%
Earnings per share
2,55
2,81
0,29
0,30
Interest and investment income
4,69 млн
4,46 млн
3,80 млн
31,76 млн
Interest expense
-
-
-
-
Net interest expenses
4,69 млн
4,46 млн
3,80 млн
31,76 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
503,64 млн
543,79 млн
558,22 млн
490,13 млн
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google колдонмолору